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background: Previous experiments have shown that granulocyte colony-stimulating factor (G-CSF), quantiﬁed in the follicular ﬂuid (FF)
of individual oocytes, correlates with the potential for an ongoing pregnancy of the corresponding fertilized oocytes among selected trans-
ferred embryos. Here we present a proof of concept study aimed at evaluating the impact of including FF G-CSF quantiﬁcation in the embryo
transfer decisions.
methods: FF G-CSF was quantiﬁed with the Luminex XMap technology in 523 individual FF samples corresponding to 116 fresh trans-
ferred embryos, 275 frozen embryos and 131 destroyed embryos from 78 patients undergoing ICSI.
results: Follicular G-CSF was highly predictive of subsequent implantation. The receiving operator characteristics curve methodology
showed its higher discriminatory power to predict ongoing pregnancy in multivariate logistic regression analysis for FF G-CSF compared
with embryo morphology [0.77 (0.69–0.83), P, 0.001 versus 0.66 (0.58–0.73), P ¼ 0.01)]. Embryos were classiﬁed by their FF G-CSF
concentration: Class I over 30 pg/ml (a highest positive predictive value for implantation), Class II from 30 to 18.4 pg/ml and Class III
,18.4 pg/ml (a highest negative predictive value). Embryos derived from Class I follicles had a signiﬁcantly higher implantation rate (IR)
than those from Class II and III follicles (36 versus 16.6 and 6%, P, 0.001). Embryos derived from Class I follicles with an optimal morph-
ology reached an IR of 54%. Frozen-thawed embryos transfer derived from Class I follicles had an IR of 37% signiﬁcantly higher than those
from Class II and III follicles, respectively, of 8 and 5% (P, 0.001). Thirty-ﬁve per cent of the frozen embryos but also 10% of the destroyed
embryos were derived from G-CSF Class I follicles. Non-optimal embryos appear to have been transferred in 28% (22/78) of the women,
and their pregnancy rate was signiﬁcantly lower than that of women who received at least one optimal embryo (18 versus 36%, P ¼ 0.04).
conclusions: Monitoring FF G-CSF for the selection of embryos with a better potential for pregnancy might improve the effectiveness
of IVF by reducing the time and cost required for obtaining a pregnancy.
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Introduction
Oocyte quality remains one of the main factors limiting the success of
assisted reproductive technology (ART) in humans. This is due to the
predominant role of maternal factors during early embryo develop-
ment and to the fragility of oocytes across their lifetime. Oocyte
morphology does not discriminate the potential for an ongoing preg-
nancy well and mainly permits negative selection (Balaban and Urman,
† These authors contributed equally to this work.
& The Author 2012. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which
permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Human Reproduction, Vol.0, No.0 pp. 1–8, 2012
doi:10.1093/humrep/des354
 Hum. Reprod. Advance Access published December 6, 2012










2006; Rienzi et al., 2010). Only 5% of fresh oocytes produce a baby.
This low rate decreases to 1% in older mothers and reaches its peak,
7%, in oocyte donation programs (Patrizio and Sakkas, 2009). The se-
lection of the optimal embryos for subsequent implantation is trad-
itionally based on morphological observation of the cohort of
embryos generated after fertilization, up to the cleavage stage (Days
2–3) or, more recently, until the blastocyst stage (Day 5). At that
stage, 20–25% of embryos transferred on Day 2 or 3 produce a
baby, and the implantation rate (IR) reaches 30–40% with transfer
at the blastocyst stage (Blake et al., 2007). Morphological observation
of embryos is effective in predicting subsequent implantation and con-
tinues to improve through the development of new non-invasive tech-
nology, such as the time-lapse imaging (Meseguer et al., 2011;
Hashimoto et al., 2012). Nonetheless, embryos morphology, especial-
ly at the early cleavage rate, does not well discriminate potentiality of
embryos for ongoing pregnancy (Guerif et al., 2007).
We have shown that granulocyte colony-stimulating factor (G-CSF),
quantiﬁed in the individual follicular ﬂuid (FF) of the corresponding
oocyte, is a non-invasive biomarker of oocyte competence in both sti-
mulated and natural IVF/ICSI cycles (Ledee et al., 2008; Ledee et al.,
2010; Ledee et al., 2011). All three studies used a multiplexed
immunobead-based assay (Xmap technology) and focused solely on
analysis of individual FF corresponding to embryos already selected
for fresh transfer. FF G-CSF concentrations signiﬁcantly predicted
the potential for live birth of the corresponding fresh transferred
embryo with a discriminatory power ranging from 0.75 to 0.83,
according to the receiving operator characteristics (ROC) method-
ology [(area under the ROC curve (AUCROC)]. In all three assays,
FF G-CSF quantiﬁcation and embryo morphological scoring appeared
to be independent predictors of implantation and were not correlated
at least until Day 3. Effective tools exist to evaluate the ovarian reserve
and have been thoroughly assessed. They can clearly predict the col-
lection of a low number of oocytes, low hormonal response to stimu-
lation, and high cancellation rates for poor response to ovarian
stimulation, but they do not provide information about individual
oocyte quality (Broer et al., 2010).
Over the last 20 years, it has been shown convincingly that the
family of colony-stimulating factors (CSF) plays a cardinal role in the
early cross-talk between mother and conceptus in both human and
animal models (Pollard, 1997; Robertson, 2007). Moreover, there is
ample evidence that CSF regulates reproductive processes at different
times during a woman’s reproductive life. The CSF family includes
macrophage CSF (M-CSF, CSF-1), granulocyte macrophage CSF
(GM-CSF, CSF-2) and granulocyte CSFs (G-CSF, CSF-3). These
CSFs are secreted glycoproteins which bind to receptor proteins,
thereby activating intracellular signalling pathways associated with cell
proliferation and differentiation (Kaushansky, 2006; Marino and
Roguin, 2008). M-, GM- and G-CSF, together with their corresponding
receptors, have been localized in the ovarian tissue (Zhao et al., 1995;
Yanagi et al., 2002; Salmassi et al., 2004; Salmassi et al., 2005a,b). All
have been detected in pre-ovulatory follicles and shown to be
secreted by granulosa cells with the maximum concentrations at ovu-
lation (Salmassi et al., 2004). G- and GM-CSF have been reported to
increase in the serum 10 days after ovulation in successful IVF/ICSI
cycles (Salmassi et al., 2005a,b).
This report describes a proof of concept study aiming to evaluate the
impact of including FF G-CSF quantiﬁcation as a new tool for selecting
the embryos with the highest potential for pregnancy among the
embryo cohorts generated after IVF/ICSI. We quantiﬁed FF G-CSF in
523 individual FF samples corresponding to the oocytes for 116 fresh
transferred embryos, 275 frozen embryos and 131 destroyed embryos.
Materials and methods
Patients
The study recruited 78 women undergoing an ICSI attempt between May
2008 andMay 2010. Each patientwas included only once. Because the proto-
col aimed to document follicular G-CSF andGM-CSF concentrations ofmor-
phologically documented oocytes at the time of the collection, we chose to
include ICSI patients only. The Institutional Review Board approved this in-
vestigation. Patients were informed that FFs would be preserved for research
purposes, in accordance with the Belgian law from December 2008 on re-
sidual biological materials. Indications for ICSI were related to pure male in-
fertility for 50 couples, mixed infertility for 14 couples or female infertility
(due to age or previous unexplained IVF failure) for 14 couples. Infertility
was primary for 61 couples and secondary for 17 couples. The mean age
of women in the cohort was 32.4 years old (20–38) and they had undergone
a mean of 1.6 previous IVF attempts (range: 1–5).
Treatment
Ovarian hyperstimulation protocols were selected by each treating phys-
ician. They included the standard long protocol with a daily GnRH agonist
for 56 patients, short protocol with a daily GnRH agonist for 18 patients
and an antagonist protocol for 4 patients. The response to stimulation
was monitored by serial hormonal blood tests and by ultrasound assessment
of follicular and endometrial growth. Ovulation was triggered with hCG
when at least four follicles had reached 17 mm. Follicles were retrieved in-
dividually by aspiration 35–36 h after ovulation induction under neuroleptic
anaesthesia and vaginal ultrasound guidance without ﬂushing of follicles.
Cumulus and coronal cells from individual oocytes collected were
removed with hyaluronidase type IV S 80 IU/ml (Sigma-Aldrichw, St-Louis,
USA). Each mature oocyte was injected under standard magniﬁcation with
a single sperm in a 5–10-ml droplet of fertilization medium (Irvine Scienti-
ﬁcw, Santa Ana, USA or LifeGlobalw, USA), with viscous polyvinyl-
pyrrolidone medium (PVP, Sigma-Aldrichw) to slow down the sperm.
Microinjection was performed with fresh ejaculated sperm in 74 cases, au-
tologous cryopreserved sperm in 3 cases and testicular cryopreserved
sperm in 1 case. The injected oocytes were individually cultured in a
20-ml microdroplet of cleavage medium (Irvine Scientiﬁcw or LifeGlobalw)
under oil, at 378C (+0.58C) in a 6% (+0.5%) CO2 humid atmosphere.
On Day 3, the embryos were analysed in relation to (a) their fragmen-
tation (0 ¼ no fragmentation, f1: 1–10%, F1: 10–30%, F2: 30–50%,
F3: over 50%); (b) blastomere regularity (0 ¼ not different in size, B1: dif-
ferent in size by a factor of ,2; B2: different in size by a factor of 2–3;
B3: different in size by a factor of .3 times; (c) ooplasmic appearance
(homogenous and clear ¼ 0, C1: 1 anomaly such as the vacuole, inclusion,
granulation or incorrect coloration; C2: 2 anomalies, C3: 3 combined
anomalies) and (d) number of blastomeres (.6 at Day 3, or not). An
embryo score was calculated and deﬁned as described in Table I. Category
A was deﬁned as optimal and required .6 cells on Day 3, 10% or less of
fragmentation and similar sizes of blastomeres.
Materials collected and analysed
The presence of an oocyte in each FF sample was assessed immediately,
and samples without an oocyte were discarded. In 15% of the cases
(80/523), two oocytes were collected in the same FF. Quantiﬁcation of
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cytokines was then applied equally to both oocytes. We were able to
analyse 523 FF samples: 116 associated with fresh transferred embryos,
276 associated with frozen embryos (among which 79 embryos subse-
quently thawed and transferred) and 131 associated with destroyed
embryos. After centrifugation, samples were divided in aliquots and
stored, initially at 2208C and then at 2808C until they were assayed.
For blinding, samples were identiﬁed only by a patient ID number, a stimu-
lation number and an oocyte number within the cohort. Attaching names
(and therefore results) to the numbers required a key not available to
those performing the test (Mediﬁrst SA, Guyancourt, France).
A Luminex system (Luminex XMap Technology from Bio-Rad) was used
to read the concentrations of two cytokines (G-CSF and GM-CSF Labor-
atoriesw, Hercules, CA, USA) in the individually collected FF. This technol-
ogy uses multiplexed microsphere-based immunoassays that apply ﬂow
cytometric resolution to measure spectrally distinct microspheres
coupled with capture molecules and reporter ﬂuorochromes bound to de-
tection antibodies.
The assays were performed according to the manufacturer’s instructions
(Bio-Rad). Each FF was diluted by 10 (with the sample diluent provided in
the kit) to improve cytokine detection. Each sample was measured in dupli-
cate. A standard curve was traced for each test with the standard provided
in the kit, according to the manufacturer’s instructions. The same FF sample
was measured in each plate for an inter-assay control. Calibration of the
Luminex system was veriﬁed before each test with the calibration kit from
Bio-Rad. The range of detection for FF G-CSF was 5.1–84.24 pg/ml. Its
intra-test variation was 3% and the inter-test variation of 12%. The range
of detection for FF GM-CSF was 3.4–21.2 pg/ml, its intra-test variation
was 3% and its inter-test variation of 24%.
Statistical analysis
To identify predictive factors of implantation or subsequent ongoing preg-
nancy, we performed multivariable logistic regression analysis, using ROC
analysis to determine the performance, sensitivity, speciﬁcity and positive
and negative predictive values of FF G-CSF and GM-CSF concentrations.
Each analyte was ﬁrst evaluated with covariate factors known to inﬂuence
outcome, such as age, attempt rank, number of oocytes collected, quantity
of gonadotrophins administered during the stimulation and the estradiol
level on the day of hCG injection.
We subsequently performed a second run that included the morpho-
logical analysis of the embryo according to the Centre de Procre´ation
Me´dicalement Assiste´e (CPMA) scoring. Embryos were ﬁrst classiﬁed as
either Grades A, B or C, and a corresponding score of 3, 2 or 1 point
was attributed to evaluate the performance of the combined FF-GCSF
and embryo score. A P-value .0.1 was used as a criterion for exclusion,
in accordance with the literature on multivariate prognostic modelling
(Steyerberg et al., 2000). Logistic ﬁtting equations combining factors
independently and signiﬁcantly associated with the outcome were con-
structed from multivariate logistic regression analysis. The following
thresholds were used to interpret the AUCROC: 0.9–1: excellent separ-
ation; 0.8–0.9: good discrimination; 0.7–0.8: fair discrimination; 0.6–
0.7: poor discrimination; 0.5–0.6: no discrimination.
The only outcome considered here was assessed at 12 weeks of amen-
orrhoea when a gestational sac with cardiac activity was (or was not)
viewed by ultrasound. IR was the ratio between the number of gestational
sacs with cardiac activity and the total number of embryos transferred. A
pregnancy rate in each studied group was the number of patients with at
least one gestational sac with cardiac activity. Neither biochemical preg-
nancies (transient hCG positive test .100 and ,1000 IU/ml without
any gestational sac) nor early abortions, deﬁned as abortion occurring
before 12 weeks of amenorrhoea with hCG .1000 IU or gestational
sac without cardiac activity, were counted as pregnancy or implantation




Of the 78 patients with fresh transfers (42 with 1 fresh embryo, 34
with 2 embryos and 2 with 3 embryos), 24 (31%) were pregnant at
12 weeks. In addition, 34 of the 78 (43.5%) had embryos frozen
after the IVF attempt. Thawing of frozen embryos allowed 79
further embryos to be transferred resulting in 10 additional ongoing
pregnancies. The overall cumulative pregnancy rate was 43.6%
(34/78) with 29 singletons and 7 sets of twins.
Samples available to evaluate the power
of discrimination of immune biomarkers
To test the discriminatory power of the putative biomarkers (G-CSF
and GM-CSF), only samples associated with an IR of either 100%
(1 embryo transfer and 1 singleton; 2 embryos transferred and
twins) or 0% were included in a multivariate regression logistic analysis.
As a single-embryo transfer policy was applied for women younger
.............................................................................................................................................................................................
Table I Deﬁnition of the embryo score used at the University of Lie`ge – CPMA.
Day 3 Excellent5 A Intermediate5 B Poor5 C Discarded 5 D
.6 cells .6 cells All others not discarded ,6 cells
E (score 0 for F, B and C) F1B1 Absence of cleavage within 24 h
f1 F1C1 .2PN
F1 B1C1 F2 and more





Fragmentation. 0: no fragmentation, f1: 1–10%, F1: 10–30%, F2: 30–50%, F3: over 50%.
Blastomere regularity. 0: not different in size, B1: different in size by a factor of ,2; B2: different in size by a factor of 2–3; B3: different in size by a factor of .3 times.
Ooplasmic appearance. 0: homogenous and clear, C1: 1 anomaly such as vacuole, inclusion, granulation or incorrect coloration; C2: 2 anomalies, C3: 3 combined anomalies.
Number of blastomeres. .6: more than 6 at Day 3, ,6: not more than 6 on Day 3.
Follicular G-CSF and embryo transfer decisions 3










than 36 years at their ﬁrst or second ICSI attempt, 13 FF samples were
directly traceable to a single pregnancy and 14 corresponded to twins.
These 27 positive samples were plotted against 139 FF samples corre-
sponding to embryos that did not implant.
Prediction of implantation: respective
interest of biomarkers
G-CSF was detected in all FF; concentrations ranged from 2 to
194 pg/ml with a median of 25.5 pg/ml. GM-CSF was detectable in
99% of FF, and concentrations ranged from 0 to 669 pg/ml with a
median of 189 pg/ml. As previously reported (Ledee et al., 2008), fol-
licular G-CSF was signiﬁcantly predictive of subsequent implantation.
The AUCROC curve in the multivariate analysis evaluating the perform-
ance of FF G-CSF in predicting ongoing pregnancy reached 0.77
(0.69–0.83) with a P value of ,0.001 indicating a fair discriminatory
power. In comparison, the AUCROC related to the embryo morph-
ology was 0.66 (0.58–0.73) (P ¼ 0.01). In contrast, the AUCROC
for FF GM-CSF was found to be 0.53 and not signiﬁcant. No signiﬁcant
differences in the FF concentrations of G-CSF and GM-CSF were
observed as a function of the ovarian stimulation protocol applied.
FF G-CSF appeared to be very sensitive (92%) with a high negative
predictive value (97%) but its speciﬁcity and positive predictive
value were low (53 and 28%, respectively). FF G-CSF and embryo
morphology on Day 3 appeared to be independent, and combining
them increased the speciﬁcity of the prediction from 53 to 77%, al-
though the sensitivity was decreased. The ‘immune-morphological’
combination allowed the positive predictive value to increase from
28 to 38% with a slight decrease in the negative predictive value
(from 97 to 93%).These data are summarized in Table II.
Figure 1 illustrates the logistic regression linking the logarithm of 195
individual FF G-CSF concentrations to the IR of the corresponding
transferred embryos.
We classiﬁed FF G-CSF in three categories: Class I: FF G-CSF over
30 pg/ml (a highest positive predictive value for implantation); Class II:
from 30 to 18.4 pg/ml and Class III: ,18.4 pg/ml (a highest negative
predictive value for implantation). Embryo morphology was also clas-
siﬁed into three categories: Category A: top quality, category B:
medium quality, category C: poor embryo quality (Table I).
Table III summarizes the distribution of 195 fresh and frozen-thawed
transferred embryos by immune-morphological category and the cor-
responding IRs. Embryos derived from oocytes retrieved from follicles
with an FF G-CSF concentration .30 pg/ml had an IR of 36.4%, sig-
niﬁcantly higher than that of embryos derived from oocytes with
Classes II (16.8%) and III (6%) (P, 0.001). Embryos morphology cate-
gorized as A had an IR of 28%, as B type, of 18% and as C type of 14%
(P ¼ 0.01). The IR of embryos classiﬁed as IA, that is, FF G-CSF con-
centration .30 pg/ml with an optimal morphology was 54%, signiﬁ-
cantly higher than all the other combinations (P, 0.001).
FF G-CSF concentration among
frozen-thawed embryos
Of the 276 frozen embryos, 44 (16%) were Class III for the FF G-CSF,
so theoretically very unlikely to implant, but 97 (35%) were Class I and
thus had high potential. Overall, 147 (53%) had not been thawed
because the patient became pregnant at the fresh transfer. During
the thawing process, 44 embryos lysed: 13 from FF G-CSF Class I,
19 from Class II and 12 from Class III. At the time of freezing, 72%
of the lysed embryos had poor morphology, ranked as C. In all, 79
embryos were successfully transferred after the thawing process.
Class I frozen-thawed embryos had a signiﬁcantly higher IR (36%)
than Class II (9%) and III (3%) derived frozen-thawed embryos.
These data are detailed in Table IV.
FF G-CSF values among destroyed embryos
G-CSF concentrations were assessed for 29 mature oocytes that failed
to cleave and be fertilized; in only 1 out of 29, the FF G-CSF concen-
tration was .30 pg/ml. All 102 embryos destroyed on Day 3 had
poor morphology, incompatible with freezing. Nonetheless, 26 were
from FF G-CSF Class I, 47 were from Class II and 29 were from
Class III. For 5 patients, the embryo with the theoretically highest po-
tential calculated from the oocyte evaluation within the available cohort
was destroyed. This ﬁnding illustrates clearly the high rate of false posi-
tivity for a follicular biomarker used alone, since it does not take into
account any of the issues related to male factors or culture conditions.
.............................................................................................................................................................................................
Table II Power of discrimination of FF G-CSF, embryo morphology and combined FF-G-CSF and embryo morphology.
FF G-CSF
(multivariate analysis)
Embryo score Implantation score (Log(P): 24.561 0.053 FF
G-CSF1 0.643 EMBRYO score)
AuROC (95% CI) 0.77 (0.69–0.83) 0.66 (0.58–0.73) 0.76 (0.69–0.83)*
P value 0.0001 0.009 0.0001
Sensitivity (FP) (%) 92.6 63 70
Speciﬁcity (FP) (%) 53.8 64 77
Positive predictive value (%) 28 26 38
Negative predictive value (%) 97 90 93
Cut-off value .23.83 pg/ml Type A or B .0.184
The combined morpho G-CSF is the result of logistic regression Log(P): 24.56 + 0.05 × FF G-CSF + 0.64 × EMBRYO score not addition of number.
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Retrospective analysis of the embryo transfer
choices and the combined
immune-morphological embryo categories
The priority for effective embryo selection is to discard embryos with
a low probability of implantation, to optimize as much as possible the
true negative rate and it also seems essential to identify embryos with
very high potential for implantation, to increase the pregnancy rate
while controlling multiple pregnancy rates. Accordingly, we evaluated
the immune-morphological score of each embryo generated from
each patient’s cohort of oocytes collected after ovarian stimulation.
Our objective was to determine if these results would have modiﬁed
the embryologist’s choice. The hypothesis was that the embryo to be
transferred fresh should be chosen according to the following rule:
IA. IB . IIA. IC . IIB. IIC . IIIA. IIIB . IIIC. As above, the
number refers to the classiﬁcation of the FF G-CSF concentration
and the letter that follows it to the embryo morphology. The choice
was deﬁned as optimal when embryos chosen for fresh transfer
were those with the highest available combination among the
cohort of embryos available on Day 3. Overall, 28% (22/78) of the
patients did not have an optimal embryo transferred. For patients
who did not receive at least one optimal embryo, the pregnancy
rate was signiﬁcantly lower than among the 56 patients who received
at least one optimal embryo (18 compared with 36%, P ¼ 0.04).
Of the 42 patients with one fresh transferred embryo, 16 (38%) did
not had the optimal embryo transferred, and this decreased
Figure 1 The IR is represented as a function of the logarithm of the follicular ﬂuid G-CSF concentration.
.............................................................................................................................................................................................
Table III Distribution of fresh and frozen-thawed embryos transferred into immuno-morphological categorizations
and IRs.
FF G-CSF (pg/ml) category No. of embryos IR (%) FF G-CSF (A-B-C) and
Embryo type (A-B-C)
No. of embryos IR (%)
I: .30 pg/ml 59 36.4** IA 27 53.7**
IB 14 28.5
IC 18 16.6
II: 18–30 pg/ml 105 16.8 IIA 36 19.4
IIB 28 16
IIC 41 14
III: ,18 pg/ml 31 6 IIIA 15 6
IIIB 6 8
IIIC 10 5
The outcome of 116 fresh transferred and 79 frozen and successfully thawed and transferred embryos is considered.
From each group of transferred embryos we may observe the number of resulting implanted embryos (number of gestational sacs).
**P, 0.001 category I versus categories II and III.
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subsequent IRs (25 versus 35%). Among these women with an initial
non-optimal choice, six subsequently became pregnant by transferring
frozen-thawed embryos with a higher immune-morphological score
than the fresh-transferred ones. As two embryos were transferred
simultaneously after the thawing process, two of these transfers
resulted in twin pregnancies. However, 61% of the embryo lysed
during thawing and 13% of the destroyed embryos were classiﬁed as
arising from Class I oocytes. Altogether our data indicate we would
have achieved a minimum of 6 additional pregnancies at the fresh
transfer stage by documenting FF G-CSF before transfer.
Of 36 patients with two or three embryos transferred, at least one
of the fresh transferred embryos was the optimal choice in 82% (30/
36) and resulted in a pregnancy rate of 37%. In contrast, no pregnancy
resulted in the 6 women for whom both fresh transferred embryos
were selected from non-optimal combinations. For these six patients,
23% of the destroyed embryos were classiﬁed as Class I and 29% of
thawed embryos lysed. In the subgroup with only one optimal
embryo transferred over 2, destruction or lysis of FF G-CSF Class I
embryos eliminated some potential pregnancies, and two pregnancies
resulted from the transfer of frozen thawed embryos. Again, we hy-
pothesize that we would have achieved 3 additional pregnancies in
that group receiving two or three embryos at the fresh embryo trans-
fer stage by documenting FF G-CSF before transfer.
Finally, our results suggest that some twin pregnancies could have
been prevented. Three of the seven sets of twins occurred in the
group with two optimal fresh embryos transferred, and all three of
these had two Class IA embryos transferred. This category of
embryo has a theoretical implantation probability of 54%, according
to our hypothesis. The combinations in the seven twin pregnancies
were the following: (i) IIA-IIA, (ii) IC-IIB, (iii) IA-IA, (iv) IA-IA, (v)
IIC-IIC, (vi) IA-IA and (vii) IIB-IIC. We may assume that the three
twins with double IA combinations could have been prevented and
anticipated. This would result in a relative reduction of 55% in the cu-
mulative multiple pregnancy rate (from 9 to 5%) while not affecting the
overall pregnancy rate.
Based on these observations, we postulate that nine additional preg-
nancies could have been expected if FFG-CSF had been assessed before
transfer, leading to a relative increase of 37.5% in the ongoing pregnancy
rate (from 24/78 to 33/78) after the fresh embryo transfer.
Discussion
This proof of concept study suggests that combining the FF G-CSF
concentration with the embryo morphology scale might improve the
effectiveness of embryo selection. It suggests that a relative increase
of 37.5% in the ongoing pregnancy rates at the ﬁrst fresh transfer is
possible by better selection of embryos with a high probability of im-
plantation. This approach would also modify some choices about
frozen and destroyed embryos, limiting the number of cryopreserved
embryos and restoring the option of fresh transfer for some destroyed
embryos. Moreover, it suggests that assessing FF G-CSF can improve
the selection of an embryo for single embryo transfer and reduce the
number of multiple pregnancies generated.
In contrast, follicular GM-CSF concentrations are not related to
corresponding ongoing pregnancy rates in contrast to its described
role in embryo supernatants or within the endometrium (Robertson,
2007). CSF-related expression appears crucial for implantation, with
each family member playing a very speciﬁc predetermined spatial
role.
As FF is easily available during oocyte collection, it is the optimal
source for non-invasive biochemical predictors (Revelli et al., 2009).
Moreover, we have previously shown that follicular G-CSF concentra-
tions are not affected by blood contamination (Ledee et al., 2008).
Compared with emerging approaches based on genomic analysis of
cumulus cells to evaluate oocyte competence (Assou et al., 2008;
Gebhardt et al., 2011), assessment of a protein such as G-CSF in an
individual FF sample is a simple and economic method for use in
daily practice.
The cost-effectiveness of such a tool to improve embryo selection
can only be evaluated in prospective randomized studies that compare
embryo selection based on morphology alone to an approach combin-
ing morphology and FF G-CSF quantiﬁcation. The hypothesis would be
that this more efﬁcient process would yield more pregnancies in less
time and at less expense. The end-points of such a prospective
study would therefore be the number of embryos per patient required
to obtain a pregnancy, the number of cycles and the time in months
required for a pregnancy, the ongoing pregnancy rate per fresh trans-
fer and the cumulative pregnancy rate per oocyte harvested.
Another fundamental issue is to determine if the use of FF G-CSF as
a biomarker of oocyte quality might also help patients with documen-
ted poor ovarian reserve. This issue was not explored here, for we
included only patients younger than 38 years. Multivariate logistic ana-
lysis including age, number of oocytes collected and hormonal re-
sponse to ovarian stimulation did not show that any of these criteria
reﬂecting ovarian reserve inﬂuenced FF G-CSF concentrations.
As shown for the anti-Mullerian hormone, which also reﬂects the
ovarian reserve (Broer et al., 2010), oocyte quantity and quality
seem to be somewhat independent concepts. Further studies must in-
vestigate if FF G-CSF might be relevant in situations of low ovarian
reserve.
As noted above, demonstration of a relative effective increase of
37.5% in the ongoing pregnancy rates through a more accurate
choice of fresh transferred embryos requires prospective randomized
studies that use daily FF G-CSF bead-based immunoassay quantiﬁca-
tion. This assessment should be performed within a day, but would
require modiﬁcation of the oocyte collection procedure. Each individ-
ual follicle must be aspirated individually and the corresponding oocyte
must be fertilized and cultured individually, to ensure traceability
(Wongtra-Ngan et al., 2010). In this study, oocyte retrieval was per-
formed by individual aspiration without ﬂushing. We found that 15%
of the FFs collected contained two oocytes. These data show the
........................................................................................
Table IV IR among frozen-thawed transferred










Category I: .30 pg/ml 21 35.7***
Category II: 18–30 pg/ml 44 8.6
Category III: ,18 pg/ml 14 3.0
***P, 0.0001 Category I versus Categories II and III.
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need for improvement if follicular G-CSF is to be used as a diagnostic
tool. Systems of aspiration with double lumen allow the aspirated fol-
licle to be ﬂushed and subsequently re-aspirated (follicular ﬂushing) to
increase individual traceability. The duration of the oocyte retrieval
procedure would undoubtedly increase, as well as patients’ discomfort
during the procedure (Hill and Levens, 2010). This change, however, is
a prerequisite for the assessment of individual FF G-CSF concentra-
tions, to increase the subsequent pregnancy rate by a more precise
and accurate choice of embryos with the best potential for implant-
ation and live birth.
A current approach for selecting embryos with a high potential for
live birth is to select them through a culture until the blastocyst stage
(Sills and Palermo, 2010). This policy has been shown to be successful
in increasing live birth rates while decreasing the number of cryopre-
served embryos when a minimum number of viable embryos are avail-
able on Day 2 or 3 (Blake et al., 2007). However, patients with a low
number of embryos on Day 2 or 3 might not be good candidates for
such a strategy, which might result in the absence of any transfer on
Day 5; they would beneﬁt from selection that uses FF G-CSF to docu-
ment the corresponding oocyte quality.
The selection of embryos through prolonged culture through the
blastocyst stage and FF G-CSF quantiﬁcation both suggest that too
many embryos without real potential for pregnancy are cryopre-
served. Here, only 35% of cryopreserved embryos were derived
from an oocyte retrieved from a high-potential follicle. Better selection
would theoretically decrease the time necessary to obtain a live birth
and would save both physicians and patients the time and money for
unsuccessful cycles of frozen thawed transfers. Another emerging ap-
plication is clearly in the area of oocyte cryopreservation, as an option
to reduce the well-known and documented impact of age and the use
of gamete donation (Setti and Bulletti, 2011). In this situation, FF
G-CSF appears to be a very promising tool because of its very high
sensitivity, compared with the low predictive value of oocyte morph-
ology (Balaban and Urman, 2006; Rienzi et al., 2010).
In conclusion, this proof of concept study suggests that quantiﬁca-
tion of follicular G-CSF may increase the ongoing pregnancy rate by
enabling a better choice of embryos, limit multiple pregnancies,
reduce embryo cryostorage and use some embryos which are current-
ly destroyed. FF G-CSF monitoring, by enabling better selection of
embryos with real potential for implantation, should improve the efﬁ-
ciency of the procedure by reducing the time and expense required for
a pregnancy to be achieved. Prospective randomized studies should be
conducted to determine whether this tool signiﬁcantly decreases the
number of embryos and the number of cycles required to obtain a
pregnancy while improving cumulative delivery rates per oocyte
harvested.
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